arrow
A

Anne Hulin

univ paris est créteil and institut national de la sante et de la recherche medicale and assistance publique des hopitaux de paris
H指数:23
被引数:2,095

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Can pharmacokinetic/pharmacodynamic targets be achieved with voriconazole in the treatment of urinary tract infections caused by Candida spp. with reduced susceptibility to fluconazole?

氟康唑敏感性降低的念珠菌属引起的尿路感染中使用伏立康唑能否达到药代动力学/药效学目标?

2026-07-220
PRE
Drug interactions and kidney safety of bictegravir/emtricitabine/tenofovir alafenamide in kidney transplant recipients with HIV: an interventional pilot study

比克替拉韦/恩曲他滨/替诺福韦艾拉酚胺在HIV感染的肾移植受者中的药物相互作用及肾脏安全性:一项干预性试点研究

2026-05-220
PRE
Potential Impact of Microbial Dysbiosis and Tryptophan Metabolites in Advanced Stages of Colorectal Cancer

微生物菌群失调及色氨酸代谢物在结直肠癌晚期阶段中的潜在影响

2025-12-230
OAAI
Regorafenib combined with irinotecan as second-line treatment in metastatic gastro-oesophageal adenocarcinomas: results of PRODIGE 58-UCGI35-REGIRI Unicancer randomised phase II study

瑞戈非尼联合伊立替康作为转移性胃食管腺癌的二线治疗:PRODIGE 58-UCGI35-REGIRI Unicancer随机II期研究的结果

2025-05-010
OA
Decreased risk of underdosing with continuous infusion versus intermittent administration of cefotaxime in patients with sickle cell disease and acute chest syndrome (vol 19, e0302298, 2024)

与间歇给药相比,连续输注头孢噻肟在镰状细胞病合并急性胸综合征患者中可降低用药不足的风险(卷 19,e0302298,2024)

2025-02-120
OA
JAK Inhibition in Aicardi-Goutieres Syndrome: a Monocentric Multidisciplinary Real-World Approach Study
2023-05-1216
OAAI
Impact of trough concentrations of regorafenib and its major metabolites M-2 and M-5 on overall survival of chemorefractory metastatic colorectal cancer patients: Results from a multicentre GERCOR TEXCAN phase II study
2022-06-018
OAAI